Nitnib 50mg Capsule (Sunitinib) | Global Oncology Exporter: USA, UK, Thailand, Australia, Singapore, Jamaica | Ernest Impex
Description
Nitnib 50mg Capsule (Sunitinib)
Detailed Product Overview: What is Nitnib 50mg?
Nitnib 50mg is a high-potency oral oncology medication containing the active ingredient Sunitinib. It is classified as a multikinase inhibitor (TKI) and is a cornerstone in the field of targeted cancer therapy. Unlike traditional chemotherapy, which non-selectively attacks all rapidly dividing cells, Nitnib is designed to identify and interfere with specific molecular pathways involved in the growth, progression, and spread of cancer cells.
Primary Therapeutic Indications
Advanced Renal Cell Carcinoma (RCC): Used as a first-line treatment for advanced kidney cancer.
Gastrointestinal Stromal Tumors (GIST): For patients with stomach or bowel tumors that have progressed or who are intolerant to imatinib therapy.
Pancreatic Neuroendocrine Tumors (pNET): Treats progressive, well-differentiated tumors located in the pancreas.
Adjuvant Treatment: Used to reduce the risk of cancer returning in high-risk patients following a nephrectomy (kidney removal).
Mechanism of Action: How Nitnib Works
Nitnib 50mg operates through a sophisticated “multi-receptor“ blockade to dismantle the biological infrastructure of a tumor.
Tyrosine Kinase Inhibition: It blocks enzymes known as Tyrosine Kinases found on the surface of cancer cells. These enzymes act as communication signals that tell the cancer cells to multiply. By blocking these signals, Nitnib halts uncontrolled cell division.
Anti-Angiogenesis Strategy: Nitnib inhibits the Vascular Endothelial Growth Factor (VEGF) and Platelet-Derived Growth Factor (PDGF) receptors. This prevents the tumor from developing its own blood vessels. By cutting off these “nutrient supply lines,“ the tumor is starved of oxygen and essential nutrients.
Apoptosis Induction: By disrupting vital survival pathways, the medication can trigger programmed cell death (apoptosis) in malignant tissues.
Clinical Instructions & Administration
To ensure maximum therapeutic efficacy and safety, follow these administration guidelines:
Dosing Schedule: Nitnib is typically administered in cycles (e.g., 4 weeks of daily treatment followed by a 2-week rest period). Strictly adhere to the specific cycle prescribed by your oncologist.
Administration: Swallow the 50mg capsule whole with water. It can be taken with or without food.
Integrity: Do not crush, chew, or open the capsule, as this can affect the absorption rate and increase the risk of side effects.
Consistency: Take your dose at the same time every day to maintain a steady concentration in your system.
Dietary Note: Avoid grapefruit and grapefruit juice, as they can significantly increase the levels of Sunitinib in your blood to unsafe levels.
Side Effects & Management
Nitnib 50mg is a powerful medication and may cause adverse reactions. Early identification is key:
Gastrointestinal: Nausea, diarrhea, vomiting, and mouth sores (stomatitis).
Dermatological: Yellowish skin discoloration (non-jaundice), dryness, or Hand-Foot Syndrome (painful redness and swelling on the palms and soles).
Cardiovascular: Hypertension (high blood pressure) is common; regular monitoring is essential.
Metabolic: Changes in thyroid function (Hypothyroidism) or altered taste (dysgeusia).
Hematological: Potential decrease in white blood cell or platelet counts, requiring periodic blood monitoring.
Storage and Handling Protocols
Environmental Control: Store in a cool, dry place away from direct sunlight and humidity.
Temperature: Maintain storage at controlled room temperature, ideally between 15°C to 30°C (59°F to 86°F).
Child Safety: Keep strictly out of reach of children.
Disposal: Do not dispose of oncology medications in household wastewater. Consult your local pharmacist for proper hazardous waste disposal.
Why Choose Ernest Impex?
✔ GMP Standards: We supply only products that meet rigorous international manufacturing benchmarks.
✔ Global Strategic Logistics: Expert handling of pharmaceutical shipments to the USA, UK, UAE, Australia, and Singapore.
✔ B2B Bulk Specialization: We are a preferred partner for international oncology clinics, hospitals, and wholesale distributors.
✔ Competitive Export Pricing: Access the cost advantages of the Indian pharmaceutical market without compromising on quality.
✔ Comprehensive Documentation: Full support with COA (Certificate of Analysis), invoices, and customs documentation.
We export Impex medicines to:
USA • UK • Australia • Singapore • South Africa • Europe • Middle East • Africa • Asia
📞 Contact Ernest Impex – Pharmaceutical Exporter from India
[GROUP OF ERNEST PHARMACEUTICALS PVT. LTD.]
🌐 Websites
www.ernestimpex.com
www.ernestpharmaceuticals.com
www.oncologuymediciensupplier.com
www.ernestvision.com
📧 Email: exports@ernestpharmaceuticals.com
📦 Business Type: Exporter | Bulk Supplier | Distributor
📲 WhatsApp: +91 93599 02383
🔗 Direct Chat: https://wa.me/919359902383
